Skip to main content
. 2022 Feb 16;23(4):2193. doi: 10.3390/ijms23042193

Figure 6.

Figure 6

Analysis of BCL-xL expression in different myeloma subtypes. Bioinformatic analysis with ONCOMINE of BCL-xL expression in Myeloma was revised. The dataset analysis of Chapman et al. [4] of BCL-xL expression in MGUS, SM, and MM was performed, and the expression was found to be higher in MGUS (* p < 0.05).